Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 1048 entries
View as:

Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT03373019 Org: User:
Start: 12/21/17 End: 03/01/21 Due: 03/01/22

Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06090994 Org: User:
Start: 10/18/24 End: 11/30/29 Due: 11/30/30

18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06655545 Org: User:
Start: 07/15/23 End: 02/01/25 Due: 02/01/26

Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02526043 Org: User:
Start: 08/31/15 End: 12/31/22 Due: 12/31/23

The Impact of Colorectal Cancer Screening on Surgical Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT06416501 Org: User:
Start: 05/11/24 End: 06/15/24 Due: 06/15/25

The Effect of Chronic Anemia on Safety Period of Tracheal Intubation in Gynecology Patients

Phase: N/A Priority: Normal
NCT ID: NCT01968525 Org: User:
Start: 04/30/13 End: 09/30/13 Due: 09/30/14

c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI

Phase: N/A Priority: Normal
NCT ID: NCT04833036 Org: User:
Start: 10/01/19 End: 11/30/22 Due: 11/30/23

Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL)

Phase: N/A Priority: Normal
NCT ID: NCT00840385 Org: User:
Start: 11/30/07 End: 11/30/10 Due: 11/30/11

Application of Left Colic Artery Preservation, Anastomotic Reinforcing Sutures and Transanal Tube in Robotic Low Anterior Resection

Phase: N/A Priority: Normal
NCT ID: NCT03609710 Org: User:
Start: 01/01/18 End: 05/30/19 Due: 05/30/20

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)

Phase: N/A Priority: Normal
NCT ID: NCT06031181 Org: User:
Start: 03/31/23 End: 12/31/30 Due: 12/31/31

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Phase: N/A Priority: Normal
NCT ID: NCT06402708 Org: User:
Start: 04/09/24 End: 05/01/30 Due: 05/01/31

Health-promoting Lifestyle in a Genetic Counseling Clinic

Phase: N/A Priority: Normal
NCT ID: NCT05545254 Org: User:
Start: 11/13/19 End: 03/04/22 Due: 03/04/23

Clinical Trial on the Effectiveness of Herbal Medicinal Mixture in Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT00656253 Org: User:
Start: 08/31/08 End: 02/28/11 Due: 02/28/12

A Phase II Study of Triple-negative Breast Cancer Brain Metastases.

Phase: N/A Priority: Normal
NCT ID: NCT04303988 Org: User:
Start: 03/30/20 End: 05/30/25 Due: 05/30/26

Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm

Phase: N/A Priority: Normal
NCT ID: NCT05907824 Org: User:
Start: 05/01/23 End: 12/31/23 Due: 12/31/24

Pulmonary Ventilation Function Between Patients With Primary and Recurrent Incisional Hernia: a Cross-sectional Study

Phase: N/A Priority: Normal
NCT ID: NCT05991024 Org: User:
Start: 03/01/23 End: 07/31/23 Due: 07/31/24

Lateral Neck Lymph Node Mapping in Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04312087 Org: User:
Start: 08/01/16 End: 12/31/22 Due: 12/31/23

Platinum Rechallenge in Patients With Platinum-sensitive mTNBC

Phase: N/A Priority: Normal
NCT ID: NCT02607215 Org: User:
Start: 11/30/15 End: 12/31/22 Due: 12/31/23

ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)

Phase: N/A Priority: Normal
NCT ID: NCT02546934 Org: User:
Start: 03/31/16 End: 04/30/20 Due: 04/30/21

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

Phase: N/A Priority: Normal
NCT ID: NCT05628922 Org: User:
Start: 07/02/22 End: 07/01/27 Due: 07/01/28

Vaccine Chatbot for Improving Influenza Vaccination Uptake

Phase: N/A Priority: Normal
NCT ID: NCT06657573 Org: User:
Start: 10/26/24 End: 03/31/25 Due: 03/31/26

Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03904927 Org: User:
Start: 02/01/19 End: 09/15/24 Due: 09/15/25

Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab

Phase: N/A Priority: Normal
NCT ID: NCT05346861 Org: User:
Start: 09/15/21 End: 10/31/24 Due: 10/31/25

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04356872 Org: User:
Start: 04/08/20 End: 03/30/23 Due: 03/30/24

Relationship Between Hypoxia and Endocrine Response in Human Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01814449 Org: User:
Start: 03/31/12 End: 05/31/14 Due: 05/31/15